Changeflow GovPing Pharma & Drug Safety PIKFYVE Inhibitor Compounds Patent Application ...
Routine Notice Added Final

PIKFYVE Inhibitor Compounds Patent Application - C07D 487/04

Favicon for changeflow.com EPO Patent Bulletin - Organic Chemistry (C07D)
Published
Detected
Email

Summary

European Patent Office published patent application EP4444316A1 for PIKFYVE inhibitor compounds and pharmaceutical compositions. The application, filed by Kineta, Inc., covers heterocyclic compounds (C07D 487/04) with therapeutic applications including neurological conditions (A61P 25/28). Inventors include Kumaravel, Macdonnell, and Peng. A1 publication indicates the application has entered the European phase and is publicly available for examination.

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The European Patent Office published patent application EP4444316A1 on April 8, 2026, covering PIKFYVE inhibitor compounds and pharmaceutical compositions for therapeutic use. The application, filed by Kineta, Inc., lists inventors Kumaravel, Macdonnell, and Peng, and classifies the invention under C07D 487/04 with related pharmaceutical compositions (A61K) and neurological applications (A61P 25/28). The A1 publication marks the application's entry into the European regional phase.

Pharmaceutical and biotechnology companies engaged in PIKFYVE inhibitor research or neurological disease therapeutics should review the published application for potential freedom-to-operate implications. IP professionals can access the full technical disclosure through the EPO register to assess claim scope and competitive landscape.

Archived snapshot

Apr 17, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

COMPOUNDS AND COMPOSITIONS THAT INHIBIT PIKFYVE

Publication EP4444316A1 Kind: A1 Apr 08, 2026

Applicants

Kineta, Inc.

Inventors

KUMARAVEL, Gnanasambandam, MACDONNELL, Madeline, PENG, Hairuo

IPC Classifications

C07D 487/04 20060101AFI20260305BHEP A61K 31/519 20060101ALI20260305BHEP A61K 31/4409 20060101ALI20260305BHEP A61K 31/5386 20060101ALI20260305BHEP A61P 25/00 20060101ALI20260305BHEP A61P 25/28 20060101ALI20260305BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Organic Chemistry (C07D)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 8th, 2026
Instrument
Notice
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
EP4444316A1

Who this affects

Applies to
Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent prosecution Drug discovery
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Healthcare

Get alerts for this source

We'll email you when EPO Patent Bulletin - Organic Chemistry (C07D) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!